Zoe Fewell () (Department of Social Medicine, University of Bristol) M. A. Hernan (Harvard School of Public Health) F. Wolfe (National Data Bank for Rheumatic Diseases, USA) K. Tilling (Department of Social Medicine, University of Bristol) H. Choi (Harvard Medical School) J. A. C. Sterne (Department of Social Medicine, University of Bristol)
Abstract
Longitudinal studies in which exposures, confounders and outcomes are measured repeatedly over time have the potential to allow causal inferences about the effects of exposure on outcome. There is particular interest in estimating the causal effects of medical treatments (or other interventions) in circumstances in which a randomised controlled trial is difficult or impossible. However, standard methods for estimating exposure effects in longitudinal studies are biased in the presence of time-dependent confounders affected by prior treatment. This talk describes the use of marginal structural models (described by Robins et al.) to estimate exposure or treatment effects in the presence of time-dependent confounders affected by prior treatment. The method is based on deriving inverse-probability-of-treatment weights, which are then used in a pooled logistic regression model to estimate the causal effect of treatment on outcome. We demonstrate the use of marginal structural models to estimate the effect of methotrexate on mortality in persons suffering from rheumatoid arthritis.
Download Info
To our knowledge, this item is not available for
download. To find whether it is available, there are three
options:
1. Check below under "Related research" whether another version of this item is available online.
2. Check on the provider's web page
whether it is in fact available.
3. Perform a search for a similarly titled item that would be
available.